The study's authors believe they are the first group to investigate the real-time relationship between alcohol consumption and AFib events.

“This is a procedure that’s done once, and it keeps giving a benefit over time,” one researcher said. “This is going to prevent thousands of strokes.”

Researchers explored data from the GALACTIC-HF trial to evaluate how the severity of a patient's reduced ejection fraction impacts the benefits of omecamtiv mecarbil.

This secondary analysis of data from the FIDELIO-DKD trial was presented May 17 at ACC.21 and published in the Journal of the American College of Cardiology. 

The solution has still only been approved in the United States for investigational use. 

The ACC is enthusiastically backing the bipartisan legislation, saying it would improve care for the country's cardiovascular patients.

The FDA has received complaints about 135 injuries so far. 

Cardiologists are confident COVID-related shortfalls will soon be behind them, according to the report. 

Percutaneous edge-to-edge mitral valve repair was associated with improved outcomes among TAVR patients with persistent mitral regurgitation. 

The new requirement covers all attendees, including exhibitors and HIMSS employees. The organization is still determining how it will validate each person's status.